Rafarma Pharmaceutical news update
Russia, Moscow, Nov. 30, 2023 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals (OTC: RAFA). The Company is pleased to announce that it has completed the restructuring, accounting and balance sheet proced...
- Supported exchanges /
- PINK /
- RAFA.PINK
Rafarma Pharmaceuticals Inc (RAFA PINK) stock market data APIs
$0.0727
0.01(15.9%)
as of October 22, 2024
Price chart is built with Anychart
Rafarma Pharmaceuticals, Inc., a multi-product pharmaceutical company, produces and sells drugs, generic antibiotics, and specialty pharmaceuticals in Russia. It offers cephalosporin-based products, antibiotics of non-ß structure, and anti-cancer drugs in the form of injections, ampulla packaged products, child suspensions, tablets, and capsules. The company also provides drugs for accidental wounds, inflammatory eye diseases, and immunological disorders. The company has a collaboration agreement with PlantEXT Ltd. to research and manufacture the first medical cannabis suppositories for patients suffering from inflammatory bowel disease. Rafarma Pharmaceuticals, Inc. was formerly known as Johnston Acquisition Corp. and changed its name to Rafarma Pharmaceuticals, Inc. in October 2012. The company is based in Sandy, Utah with a manufacturing and distribution facility in Russia. As of October 19, 2020, Rafarma Pharmaceuticals, Inc. operates as a subsidiary of R. & D. Biocogency Laboratories Inc. Ltd.
Rafarma Pharmaceuticals Inc Financial Data Overview
| 0.063 | |
| 0.0727 | |
| - | |
| 0.0727 | |
| 0.063 | |
| 0.033-0.427 | |
| 5 529 K | |
| 87 767 K | |
| 133 K | |
| 0.0002 | |
| 1.372 |
Our easy-to-use no-coding solutions help you get the data effortlessly:
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
General: {
Code:
'RAFA',
Type:
'Common Stock',
Name:
'Rafarma Pharmaceuticals Inc',
Exchange:
'PINK',
CurrencyCode:
'USD',
CurrencyName:
'US Dollar',
CurrencySymbol:
'$',
CountryName:
'USA',
CountryISO:
'US',
OpenFigi:
'BBG000DC3M97',
ISIN:
NULL,
CUSIP:
NULL,
CIK:
'1713863',
EmployerIdNumber:
NULL,
FiscalYearEnd:
'December',
IPODate:
NULL,
InternationalDomestic:
NULL,
Sector:
'Healthcare',
Industry:
'Drug Manufacturers - Specialty & Generic',
HomeCategory:
NULL,
IsDelisted:
false,
}
Rafarma Pharmaceuticals Inc Fundamental Data is available in our Financial Data APIs
- Net Revenue 133 K
- EBITDA 0
- Earnings Per Share -0.014
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get Rafarma Pharmaceuticals Inc Earnings via APIs
- Latest Release 2024-06-30
- EPS/Forecast NaN
Get Rafarma Pharmaceuticals Inc End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Get Rafarma Pharmaceuticals Inc latest news via APIs
Rafarma Pharmaceuticals strengthens its position in Central Asia
RAFARMA PHARMACEUTICALS INC Nicosia, Cyprus, April 29, 2022 (GLOBE NEWSWIRE) -- Representatives of Rafarma Pharmaceuticals, Inc. (OTC: RAFA) visited Uzbekistan and discussed the prospects for the com...
- BLOOD PLASMA
- PHARMACEUTICAL INDUSTRY
- PHARMACEUTICALS
- UZBEKISTAN
Do you have any questions?
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also:
